COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois VALNEVA : Rapport Semestriel 2025
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois Focus on sustainable profitability: Komax Group reduces costs considerably Komax Group achieves sustainable profitability by reducing costs considerably amid market challenges. Positive EBIT and cost savings of CHF 25 million confirmed in 2025 half-year results Market Challenges EBIT Cost Reduction Komax Group Sustainable Profitability
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid Sonova expands Infinio range with Phonak's smallest rechargeable in-the-ear hearing aid, Phonak Virto R Infinio. The launch marks an important step in entering the market segment Sonova Hearing Aid Phonak Infinio Rechargeable
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois LLB successfully concludes share repurchase programme Liechtensteinische Landesbank AG successfully concludes share repurchase programme holding 1.4% of share capital Share Repurchase Capital Structure Liechtensteinische Landesbank LLB Treasury Management
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals initiates Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizophrenia patients, targeting TRS population Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS Program
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates Valneva SE reports €97.6 million revenues in H1 2025, confirms 2025 financial outlook. Highlights financial results, R&D progress, and commercial updates Revenues Financial Results Valneva SE R&D Progress 2025 Outlook Commercial Updates
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 07:00, il y a 1 année 2 mois Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités. Chiffre d’affaires en hausse, trésorerie solide et perspectives confirmées. Détails disponibles sur le site de la société Résultats Financiers Perspectives Valneva Vaccins Premier Semestre 2025
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 06:55, il y a 1 année 2 mois PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range PolyPeptide Group reports +24% revenue growth in H1 2025, revises full-year guidance towards upper range. EBITDA improved to EUR 4.4 million, major investments in capacity expansion projects EBITDA Revenue Growth Capacity Expansion PolyPeptide Group Full-year Guidance
COMMUNIQUÉ DE PRESSE publié le 12/08/2025 à 06:55, il y a 1 année 2 mois TAG Immobilien AG reports strong growth in FFO I and EPRA NTA in the first half of 2025; positive valuation results in Germany and Poland; further decline in LTV TAG Immobilien AG reports strong growth in FFO I and EPRA NTA in the first half of 2025; positive valuation results in Germany and Poland; further decline in LTV TAG Immobilien AG EPRA NTA LTV FFO I Valuation Results
Publié le 09/11/2026 à 18:30, il y a 7 heures 58 minutes Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Publié le 09/11/2026 à 18:30, il y a 7 heures 58 minutes Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Publié le 09/11/2026 à 17:45, il y a 8 heures 43 minutes Déclaration hebdomadaire de rachat d'actions
Publié le 09/11/2026 à 17:45, il y a 8 heures 43 minutes Déclaration des droits de vote à fin octobre 2026
Publié le 09/11/2026 à 23:10, il y a 3 heures 18 minutes Ur-Energy Reports Third Quarter 2026 Results
Publié le 09/11/2026 à 23:00, il y a 3 heures 28 minutes LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Publié le 09/11/2026 à 22:32, il y a 3 heures 56 minutes Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Publié le 09/11/2026 à 22:15, il y a 4 heures 13 minutes Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Publié le 10/11/2026 à 01:20, il y a 1 heure 8 minutes US defence customer steps up orders and first graphene oxide orders secured
Publié le 09/11/2026 à 22:54, il y a 3 heures 34 minutes EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Publié le 09/11/2026 à 22:10, il y a 4 heures 18 minutes Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Publié le 09/11/2026 à 22:05, il y a 4 heures 23 minutes Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders